Changes on Pain and Range of Motion by the Use of Kinesio Taping in Patients Diagnosed With Cervical Pain

December 21, 2016 updated by: Fco. Javier Montanez Aguilera, Cardenal Herrera University

Changes on Pain and Range of Motion by the Use of Kinesio Taping in With Its Corrective of Space Variant on Upper Trapezius Muscle in Patients Diagnosed With Cervical Pain

The aim of this study is to demonstrate that the application of Kinesio Taping on a myofascial trigger point in the trapezius muscle able to cause a decrease of the pain and an increase of the cervical range of motion in patients diagnosed with cervical pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The use of Kinesio Taping has become very popular for the treatment of many musculoskeletal disorders in recent decades. Of the six variants of application that has the Kinesio Taping, the space correction technique is suggested for pain management. The increased space achieved with this variant decreases the pressure by raising the skin directly over the treatment area, reducing chemical irritation receptors and therefore pain. The aim of this study is to demonstrate that the application of this variant of Kinesio Taping on a myofascial trigger point in the trapezius muscle able to cause a decrease of the pain and an increase of the cervical range of motion in patients diagnosed with cervical pain. For this, the pressure pain threshold will be measured with a algometer on the trigger point, the perception of pain with a visual analog scale and the range of motion with a cervical goniometer.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
    • Valencia
      • Moncada, Valencia, Spain, 46113
        • CEU Cardenal Herrera University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Agree to participate in the study (signed informed consent)
  • Presence of active myofascial trigger point in upper trapezius.
  • Presence of neck pain

Exclusion Criteria:

  • Subjects in which not clearly identified myofascial trigger point in the upper trapezius .
  • Subjects who suffer or have suffered pathologies of upper limb deformities or orthopedic injuries that can alter static and biomechanics of shoulder and neck.
  • Subjects who suffer or have suffered rheumatic or neurological disease or chronic shoulder pain and/or neck
  • Subjects diagnosed with fibromyalgia, myelopathy or radiculopathy.
  • Subjects suffering from any psychiatric disorder (such as anxiety or depression).
  • Subjects who have suffered post-traumatic alteration (whiplash type) or cervical surgery.
  • Pregnancy risk of abortion.
  • Have used analgesics in the 48 hours before participating in the study
  • Subjects presenting any contraindications to the application of Kinesio Taping.
  • Know the Kinesio Taping technique applied in the study.
  • Be receiving physical therapy for any shoulder or neck pathology.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Sham Kinesio Taping
Four Kinesio Taping strips will be placed without tension on skin forming an asterisk. The point of intersection of the four strips will be just above the myofascial trigger point. The subject will remain three days with the strips on his skin
Device: Sham Kinesio Taping
Four Kinesio Taping strips will be placed without tension on skin forming an asterisk. The point of intersection of the four strips will be just above the myofascial trigger point. The subject will remain three days with the strips on his skin
Experimental: Kinesio Taping
Four Kinesio Taping strips will be placed with tension on skin forming an asterisk. The point of intersection of the four strips will be just above the myofascial trigger point. The subject will remain three days with the strips on his skin
Device: Kinesio Taping
Four Kinesio Taping strips will be placed with tension on skin forming an asterisk. The point of intersection of the four strips will be just above the myofascial trigger point. The subject will remain three days with the strips on his skin

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in pressure pain threshold
Time Frame: At the beginning, immediately after intervention and at 72 hours
Is defined as the minimum force applied which induces pain on myofascial trigger point. Pressure will be applied with algometer
At the beginning, immediately after intervention and at 72 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in cervical range of motion
Time Frame: At the beginning, immediately after intervention and at 72 hours
Cervical range of motion is measuring movement around this segment of the spine. Lateral flexion and rotation. Will be measured with a cervical goniometer
At the beginning, immediately after intervention and at 72 hours
Changes in pain perception
Time Frame: At the beginning, immediately after intervention and at 72 hours
It is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Will be measured with a visual analog scale
At the beginning, immediately after intervention and at 72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cardenal Herrera University

Investigators

  • Study Director: F Javier Montañez-Aguilera, PhD, CEU Cardenal Herrera University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2016

Primary Completion (Actual)

November 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

September 18, 2016

First Submitted That Met QC Criteria

September 22, 2016

First Posted (Estimate)

September 26, 2016

Study Record Updates

Last Update Posted (Estimate)

December 22, 2016

Last Update Submitted That Met QC Criteria

December 21, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CEU Cardenal Herrera

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobility Limitation

Clinical Trials on Kinesio Taping

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe